0001179110-18-012095.txt : 20181009 0001179110-18-012095.hdr.sgml : 20181009 20181009161254 ACCESSION NUMBER: 0001179110-18-012095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181008 FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vandervoort Adam C CENTRAL INDEX KEY: 0001375088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 181113792 MAIL ADDRESS: STREET 1: 485 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2018-10-08 0 0001477449 Teladoc Health, Inc. TDOC 0001375088 Vandervoort Adam C C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Legal Officer, Secretary Common Stock 2018-10-08 4 M 0 2734 8.71 A 2934 D Common Stock 2018-10-08 4 M 0 456 9.60 A 3390 D Common Stock 2018-10-08 4 M 0 914 12.21 A 4304 D Common Stock 2018-10-08 4 M 0 1447 22.30 A 5751 D Common Stock 2018-10-08 4 S 0 5551 73.83 D 200 D Employee Stock Option (right to buy) 8.71 2018-10-08 4 M 0 2734 0.00 D 2025-02-25 Common Stock 2734 13670 D Employee Stock Option (right to buy) 9.60 2018-10-08 4 M 0 456 0.00 D 2025-05-29 Common Stock 456 3645 D Employee Stock Option (right to buy) 12.21 2018-10-08 4 M 0 914 0.00 D 2026-03-07 Common Stock 914 15530 D Employee Stock Option (right to buy) 22.30 2018-10-08 4 M 0 1447 0.00 D 2027-03-03 Common Stock 1447 41955 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Represents the weighted average price of transactions ranging from $73.30 to $74.62. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort 2018-10-09